Home / Health / India's NDD Market Surges: Rs 1,893 Cr by 2034
India's NDD Market Surges: Rs 1,893 Cr by 2034
4 Apr
Summary
- Autism therapy market in India to reach ₹1,893.2 crore by CY34.
- India's developmental delays therapy market is projected to reach ₹612.3 crore.
- A shortage of trained professionals challenges the NDD care ecosystem.
The Indian market for neurodevelopmental disorder (NDD) care is witnessing substantial expansion, with projected figures indicating significant financial growth by CY34. Specifically, the Autism Spectrum Disorder (ASD) therapy market is anticipated to reach approximately ₹1,893.2 crore. Concurrently, the broader developmental delays therapy market is expected to achieve ₹612.3 crore.
This growth is fueled by heightened awareness, particularly around World Autism Day, leading more families to seek professional interventions for children with conditions such as autism, speech disorders, and Down's Syndrome. For-profit social enterprises are playing a crucial role in providing personalized programs.
However, the burgeoning NDD care ecosystem faces a significant hurdle: a shortage of trained professionals, including developmental paediatricians, child psychologists, and speech therapists. This scarcity impedes the capacity to adequately address the increasing needs of diagnosed children across India.
Despite these challenges, organizations like Rays of Belief Ltd. are actively supporting children, demonstrating the potential for impactful intervention. The industry also includes various specialized organizations, NGOs, hospitals, and regional providers contributing to the care landscape.
